Erschienen in:
01.11.2013 | Letter to the Editor
Pharmaceutical Sales Representatives and Patient Safety
verfasst von:
Donald W. Light, PhD
Erschienen in:
Journal of General Internal Medicine
|
Ausgabe 11/2013
Einloggen, um Zugang zu erhalten
Excerpt
T o the Editor: In the first study to use identical data collection methods over the same period in three different jurisdictions, Mintzes et al. found that 98 % of the time, pharmaceutical reps failed to provide minimally adequate safety information about drugs to physicians.
1 Worse, serious harms were rarely mentioned for drugs identified as harmful, and companies kept promoting them. This represents systematic untruthful abuse of First Amendment commercial free speech. …